TPST Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $100,001.36

Insider Selling (Last 12 Months): $966,798.90

Tempest Therapeutics Insider Trading History Chart

Tempest Therapeutics Share Price & Price History

^$0.83

▲ +0.0212 (2.61%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Tempest Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/12/2024	Versant Venture Capital Vi, L.	Major Shareholder	Sell	387,999	$1.10	$426,798.90	209,941
8/8/2024	Versant Venture Capital Vi, L.	Major Shareholder	Sell	400,000	$1.35	$540,000.00	597,940
7/3/2024	Stephen R Brady	CEO	Buy	35,000	$2.11	$73,850.00	46,376
7/2/2024	Samuel Whiting	Insider	Buy	4,672	$2.13	$9,951.36	9,573
6/28/2024	Justin Trojanowski	Insider	Buy	7,500	$2.16	$16,200.00	22,168
4/29/2022	Thomas Woiwode	Director	Buy	2,118,644	$2.36	$4,999,999.84	2,118,644

SEC Filings (Institutional Ownership Changes) for Tempest Therapeutics (NASDAQ:TPST)

22.52% of Tempest Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tempest Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Millennium Management LLC	189,506	$0.16M	0.0%	N/A	0.434%
2/14/2025	Jane Street Group LLC	493,094	$0.41M	0.0%	N/A	1.130%
2/14/2025	Northern Trust Corp	67,815	$57K	0.0%	+233.2%	0.155%
2/13/2025	XTX Topco Ltd	160,807	$0.13M	0.0%	+570.3%	0.368%
2/12/2025	Geode Capital Management LLC	354,276	$0.30M	0.0%	+61.0%	0.812%
2/12/2025	Versant Venture Management LLC	3,507,055	$2.93M	3.4%	N/A	8.036%
2/11/2025	Virtu Financial LLC	43,105	$36K	0.0%	N/A	0.099%
11/16/2024	Geode Capital Management LLC	220,067	$0.31M	0.0%	+42.7%	0.873%
11/15/2024	XTX Topco Ltd	23,989	$34K	0.0%	N/A	0.095%
11/5/2024	Empower Advisory Group LLC	35,000	$49K	0.0%	N/A	0.139%
10/29/2024	Fullcircle Wealth LLC	62,000	$87K	0.0%	N/A	0.279%
8/9/2024	Dimensional Fund Advisors LP	25,084	$55K	0.0%	N/A	0.113%
5/20/2024	Virtu Financial LLC	28,574	$0.11M	0.0%	+69.2%	0.129%
2/15/2024	MayTech Global Investments LLC	10,000	$44K	0.0%	N/A	0.052%
8/14/2023	Rock Springs Capital Management LP	536,214	$0.68M	0.0%	-34.9%	4.026%
8/11/2023	Sectoral Asset Management Inc.	219,394	$0.28M	0.0%	N/A	1.893%
2/14/2022	Maven Securities LTD	77,377	$0.41M	0.0%	-39.0%	1.120%
11/15/2021	Franklin Resources Inc.	15,240	$0.22M	0.0%	N/A	0.227%
11/12/2021	Renaissance Technologies LLC	34,104	$0.49M	0.0%	+26.9%	0.509%
11/9/2021	BlackRock Inc.	82,698	$1.20M	0.0%	+1,581.2%	1.234%
11/9/2021	Monashee Investment Management LLC	60,000	$0.87M	0.2%	-47.2%	0.896%
8/18/2021	Ikarian Capital LLC	89,865	$1.01M	0.1%	N/A	7.076%
8/17/2021	Boothbay Fund Management LLC	10,477	$0.12M	0.0%	N/A	0.825%
8/16/2021	Maven Securities LTD	106,628	$1.20M	0.0%	N/A	8.396%
8/13/2021	Renaissance Technologies LLC	26,867	$0.30M	0.0%	N/A	2.116%
8/13/2021	Knott David M	13,833	$0.16M	0.1%	N/A	1.089%
8/13/2021	Vanguard Group Inc.	61,150	$0.68M	0.0%	N/A	4.815%
8/13/2021	FMR LLC	647,898	$7.24M	0.0%	N/A	51.016%
8/12/2021	Monashee Investment Management LLC	113,644	$1.27M	0.2%	N/A	8.948%
5/19/2021	Squarepoint Ops LLC	84,879	$0.10M	0.0%	N/A	0.446%
5/17/2021	Ikarian Capital LLC	1,348,021	$1.62M	0.1%	+897.1%	7.079%
5/17/2021	Goldman Sachs Group Inc.	20,883	$25K	0.0%	-50.9%	0.110%
5/14/2021	Dimensional Fund Advisors LP	51,219	$61K	0.0%	+259.3%	0.269%
5/14/2021	Monashee Investment Management LLC	500,000	$0.60M	0.1%	N/A	2.626%
5/13/2021	Barclays PLC	42,638	$51K	0.0%	-90.8%	0.224%
5/13/2021	Renaissance Technologies LLC	924,801	$1.11M	0.0%	+66.0%	4.856%
5/13/2021	Knott David M	137,900	$0.17M	0.1%	N/A	0.724%
5/11/2021	Acadian Asset Management LLC	291,230	$0.35M	0.0%	+189.9%	1.529%
5/7/2021	BlackRock Inc.	139,319	$0.17M	0.0%	+9.8%	0.732%
2/24/2021	Virtu Financial LLC	30,755	$66K	0.0%	N/A	0.162%
2/19/2021	JPMorgan Chase & Co.	75,264	$0.16M	0.0%	+8,328.2%	0.396%
2/11/2021	Barclays PLC	464,390	$0.99M	0.0%	+355.7%	2.444%
2/10/2021	Renaissance Technologies LLC	557,108	$1.19M	0.0%	+4.1%	2.932%
2/9/2021	Bank of New York Mellon Corp	56,397	$0.12M	0.0%	N/A	0.297%

Data available starting January 2016

See Full Table

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.

Today's Range

Now: $0.83

$0.82

$0.89

50 Day Range

MA: $0.89

$0.78

$0.99

52 Week Range

Now: $0.83

$0.70

$6.00

Volume

1,194,488 shs

Average Volume

2,111,109 shs

Market Capitalization

$36.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Tempest Therapeutics?: Tempest Therapeutics' top insider investors include:
Versant Venture Capital Vi, L (Major Shareholder)
Stephen R Brady (CEO)
Justin Trojanowski (Insider)
Samuel Whiting (Insider)
Learn More about top insider investors at Tempest Therapeutics.
Who are the major institutional investors of Tempest Therapeutics?: Tempest Therapeutics' top institutional investors include:
Versant Venture Management LLC — 8.04%
Jane Street Group LLC — 1.13%
Geode Capital Management LLC — 0.81%
Millennium Management LLC — 0.43%
XTX Topco Ltd — 0.37%
Northern Trust Corp — 0.16%
Learn More about top institutional investors of Tempest Therapeutics stock.
Which institutional investors are selling Tempest Therapeutics stock?: Within the last quarter, TPST stock was sold by these institutional investors:
Citadel Advisors LLC
Which institutional investors are buying Tempest Therapeutics stock?: During the last quarter, TPST stock was purchased by institutional investors including:
Versant Venture Management LLC
Jane Street Group LLC
Millennium Management LLC
XTX Topco Ltd
Geode Capital Management LLC
Northern Trust Corp
Virtu Financial LLC
Group One Trading LLC
Within the previous year, these company insiders have bought Tempest Therapeutics stock:
Versant Venture Capital Vi, L (Major Shareholder)
Stephen R Brady (CEO)
Justin Trojanowski (Insider)
Learn More investors buying Tempest Therapeutics stock.